{
  "created_at": "Wed Feb 03 13:3:3 +0000 2021",
  "id_str": "1356936115693961216",
  "full_text": "Russia's Sputnik V vaccine gives around 92% protection against Covid-19, according to trial results published in The Lancet, a scientific journal. Our film from last week explains why distributing vaccines to the world is a major challenge https://t.co/ThFemvIwBt",
  "display_text_range": [
    0,
    263
  ],
  "entities": {
    "hashtags": [],
    "symbols": [],
    "user_mentions": [],
    "urls": [
      {
        "url": "https://t.co/ThFemvIwBt",
        "expanded_url": "https://econ.st/3atARYH",
        "display_url": "econ.st/3atARYH",
        "indices": [
          240,
          263
        ]
      }
    ]
  },
  "user": {
    "name": "The Economist",
    "screen_name": "TheEconomist",
    "profile_image_url_https": "https://pbs.twimg.com/profile_images/879361767914262528/HdRauDM-_normal.jpg"
  },
  "retweet_count": 34,
  "favorite_count": 93,
  "possibly_sensitive": false,
  "original_created_at": "Wed Feb 03 12:02:35 +0000 2021",
  "localize": [
    {
      "locale": "zh",
      "full_text": "根据发表在科学杂志《柳叶刀》上的试验结果，俄罗斯的Sputnik V疫苗对Covid-19提供了约92%的保护。我们上周的影片解释了为什么向全世界分发疫苗是一项重大挑战https://t.co/ThFemvIwBt。"
    },
    {
      "locale": "zh-Hant",
      "full_text": "根據發表在科學雜誌《柳葉刀》上的試驗結果，俄羅斯的Sputnik V疫苗對Covid-19提供了約92%的保護。我們上週的影片解釋了爲什麼向全世界分發疫苗是一項重大挑戰https://t.co/ThFemvIwBt。"
    }
  ]
}